If you wish to receive Everest Medicines Limited information by email, please choose your options for email notification, enter your email address and information below and click "Submit".
2022-09-30
DALAY IN DESPATCH OF CIRCULAR
2022-09-19
(1) GRANT OF OPTIONS (2) NON-EXEMPT CONNECTED TRANSACTION — PROPOSED AWARD GRANT TO A CONNECTED PERSON (3) NON-EXEMPT CONNECTED TRANSACTION — PROPOSED PERFORMANCE TARGET AWARD GRANT TO A CONNECTED PERSON
2022-09-19
APPOINTMENT OF EXECUTIVE DIRECTOR AND CHIEF EXECUTIVE OFFICER
2022-09-01
NOTIFICATION LETTER WITH REQUEST FORM TO NON-REGISTERED HOLDERS
2022-09-01
NOTIFICATION LETTER WITH CHANGE REQUEST FORM TO REGISTERED SHAREHOLDERS
2022-08-26
RESIGNATION OF EXECUTIVE DIRECTOR AND CHIEF EXECUTIVE OFFICER
2022-08-24
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2022
2022-08-24
CHANGE OF ADDRESS OF PRINCIPAL PLACE OF BUSINESS IN HONG KONG
2022-08-16
(1) MAJOR TRANSACTION IN RELATION TO THE TERMINATION AND TRANSITION SERVICES AGREEMENT AND (2) CHANGE IN USE OF PROCEEDS FROM THE GLOBAL OFFERING
